Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GeneDx Holdings Corp. (WGS : NSDQ)

• Company Description    GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. Number of Employees: 1,300

• Price / Volume Information    Yesterday's Closing Price: $47.31 Daily Weekly Monthly 20 Day Moving Average: 2,102,878 shares Shares Outstanding: 29.69 (millions) Market Capitalization: $1,404.54 (millions) Beta: 2.06 52 Week High: $170.87 52 Week Low: $32.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -28.58% -32.07% 12 Week -41.87% -46.26% Year To Date -63.62% -66.54%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 333 Ludlow Street North Tower 6th Floor - Stamford,CT 06902 USA ph: 888-729-1206 fax: - investors@genedx.com http://www.genedx.com

• General Corporate Information    Officers Katherine Stueland - Chief Executive Officer and Director Jason Ryan - Chairman Kevin Feeley - Chief Financial Officer Eli D. Casdin - Director Emily Leproust - Director Peer Information GeneDx Holdings Corp. (CHCR) GeneDx Holdings Corp. (ESRX) GeneDx Holdings Corp. (MYDP) GeneDx Holdings Corp. (COR) GeneDx Holdings Corp. (GBCS) GeneDx Holdings Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 81663L200 SIC: 8000 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 29.69 Most Recent Split Date: 5.00 (0.03:1) Beta: 2.06 Market Capitalization: $1,404.54 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.19 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.00 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 55.66 PEG Ratio: - Price Ratios Price/Book: 5.53 Price/Cash Flow: 20.64 Price / Sales: 3.17 EPS Growth vs. Year Ago Period: -200.00% vs. Previous Quarter: -300.00% Sales Growth vs. Year Ago Period: 17.38% vs. Previous Quarter: -15.48% ROE 03/31/26 - 9.15 12/31/25 - 14.73 09/30/25 - 20.22 ROA 03/31/26 - 5.21 12/31/25 - 8.67 09/30/25 - 11.89 Current Ratio 03/31/26 - 3.09 12/31/25 - 2.46 09/30/25 - 2.71 Quick Ratio 03/31/26 - 2.95 12/31/25 - 2.34 09/30/25 - 2.59 Operating Margin 03/31/26 - 5.85 12/31/25 - 9.78 09/30/25 - 13.47 Net Margin 03/31/26 - -17.58 12/31/25 - -4.92 09/30/25 - 0.52 Pre-Tax Margin 03/31/26 - -17.50 12/31/25 - -4.94 09/30/25 - 0.62 Book Value 03/31/26 - 8.56 12/31/25 - 10.54 09/30/25 - 10.11 Inventory Turnover 03/31/26 - 11.07 12/31/25 - 10.54 09/30/25 - 10.66 Debt-to-Equity 03/31/26 - 0.38 12/31/25 - 0.16 09/30/25 - 0.18 Debt-to-Capital 03/31/26 - 27.57 12/31/25 - 13.52 09/30/25 - 15.00

Powered by Zacks Investment Research ©